EQRx is a biotechnology company focused on developing important new medicines and offering them at lower prices through strategic partnerships with stakeholders from across the healthcare system and cutting-edge science and technology.

Total Funding to Date$813.88MM
Register for Details

For more details on financing and valuation for EQRx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

EQRx Ticker Symbol


EQRx Stock Price

$3.78 as of 12/2/22

EQRx Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
1/11/2021 Series B $570MM raised $XXX.XX $XXX.XX
1/13/2020 Series A $243.88MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data